AEON Biopharma (AEON) Non-Current Assets (2021 - 2026)
AEON Biopharma's Non-Current Assets was $1.92 million in Q2 2026, up 36.9% from $1.4 million a year earlier.
Powered by 
Analysis
AEON Biopharma (AEON) Non-Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at AEON Biopharma came in at $2.16 million, up 39.3% from FY2024.
- Non-Current Assets shows a four-year compound annual growth rate of -70.3% (FY2021 to FY2025).
- In earlier years, Non-Current Assets was $1.55 million in FY2024 (+149.1%), $623,000 in FY2023 (-33.7%), $940,000 in FY2022 (-99.7%) and $276.11 million in FY2021.
- Quarterly Non-Current Assets has moved between $534,000 (Q1 2024) and $277.16 million (Q3 2022) over five years.
- Compared with a year earlier, Non-Current Assets was higher in four of the last six quarters, with growth averaging 60.8%.
- The best year-over-year quarter for Non-Current Assets over five years was Q1 2025 (growth of 176.8%); the worst was Q4 2022 (a decline of 99.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,158.62 Bn | 1,127.21 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 624.60 Bn | 543.13 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 511.56 Bn | 484.67 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 366.61 Bn | 320.99 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 297.15 Bn | 261.14 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 260.94 Bn | 234.63 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 234.46 Bn | 189.86 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 193.49 Bn | 167.69 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 159.77 Bn |
| 10 | AEON Biopharma | 11.95 Mn | -8.86 Mn | - | 1.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.92 Mn |
| Dec 31, 2025 | 2.16 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 1.63 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 534,000.00 |
| Dec 31, 2023 | 623,000.00 |
| Sep 30, 2023 | 708,000.00 |
| Jun 30, 2023 | 21.19 Mn |
| Mar 31, 2023 | 21.07 Mn |
| Dec 31, 2022 | 940,000.00 |
| Sep 30, 2022 | 277.16 Mn |
| Jun 30, 2022 | 276.27 Mn |
| Mar 31, 2022 | 276.13 Mn |
| Dec 31, 2021 | 276.11 Mn |
| Sep 30, 2021 | 276.17 Mn |
| Jun 30, 2021 | 276.23 Mn |
API Access
AEON Biopharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=AEON&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "AEON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=AEON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();